Table 2 Clinical characteristics of recruited patients (n=20) divided into different diagnostic groups

AML/ALL

11.3 ± 3.8

1.34 ± 0.2

4 (20)

Cancer predisposition

12.7 ± 3.1

1.40 ± 0.1

4 (20)

Solid tumours

11.0 ± 4.9

1.38 ± 0.3

3 (15)

Lymphoma

17.0 ± 0.8

1.70 ± 0.1

3 (15)

FUO

15.2 ± 2.6

1.55 ± 0.1

2 (10)

CRMO

14.0

1.56

1 (5)

Langerhans cell histiocytosis

13.5 ± 1.5

1.62 ± 0.1

2 (10)

Sickle cell anaemia

8.0

1.30

1 (5)